Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours Β· Estimated delivery Sep 2 - Sep 7
It is not yet approved by the MHRA or EMA
MC4R activation in the hypothalamus suppresses appetite and stimulates sexual arousal pathways through NO-dependent mechanisms, which led to the development of PT-141 (bremelanotide) as a focused MC4R agonist for sexual dysfunction
Hajnal A, Zharikov A, Polston JE, Fields MR, Tomasko J, Rogers AM, et al
Notable GLP-1 drugs include: Market Size and Growth With 77.72% of worldwide sales in 2024, North America remains the primary market for GLP-1 drugs
US$ 25.24
US$ 27.12
US$ 24.04
US$ 27.07
US$ 28.27
US$ 21.66
